A Pilot Study of Radioimmunodetection of 124-Iodine-labeled Humanized A33 Antibody (124I-huA33) in Patients With Colorectal Cancer

Trial Profile

A Pilot Study of Radioimmunodetection of 124-Iodine-labeled Humanized A33 Antibody (124I-huA33) in Patients With Colorectal Cancer

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 04 May 2017

At a glance

  • Drugs Iodine-124-monoclonal antibody A33 (Primary) ; Monoclonal antibody A33; Monoclonal antibody A33
  • Indications Colorectal cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 01 May 2017 Planned End Date changed from 1 Jun 2017 to 1 Jun 2018.
    • 01 May 2017 Planned primary completion date changed from 1 Jun 2017 to 1 Jun 2018.
    • 28 Apr 2016 Planned End Date changed from 1 Jun 2016 to 1 Jun 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top